Bank of Montreal’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
PA
KCM
EAM
PM
LCM
Bank of Montreal's ALDX Position: Q3 2022 in Review
Bank of Montreal sold out of Aldeyra Therapeutics (ALDX) in Q3 2022, closing a stake of 80,700 shares — an estimated $324 sold.
Bank of Montreal first reported a position in ALDX in Q2 2018 and held it in 13 quarters. The position peaked at $3.17M in Q4 2020. 89 funds tracked by Wall St. Rank hold ALDX as of Q3 2022.
- Bank of Montreal reported no remaining Aldeyra Therapeutics position as of Q3 2022 after selling out during the quarter.
- Bank of Montreal sold 80,700 Aldeyra Therapeutics shares in Q3 2022, an estimated $324.
- Bank of Montreal first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 13 quarters.
- Bank of Montreal's Aldeyra Therapeutics position peaked at $3.17M in Q4 2020.
- 89 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2022.
Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.